Joshua Harris writes for European Pharmaceutical Review
- Patent & IP
Joshua Harris writes for European Pharmaceutical Review about how patent monetization, including systems like the Unified Patent Court (UPC), enables European pharmaceutical companies to remain competitive and ensure R&D investment and innovation.